{"schema_version":"secwatch.filing_event.v1","accession":"0001628908-24-000117","form_type":"8-K","ticker":"EVH","cik":"0001628908","company_name":"Evolent Health, Inc.","filed_at":"2024-12-11T23:59:59+00:00","discovered_at":"2026-05-14T18:03:09.033788+00:00","generated_at":"2026-05-29T04:43:43.026826+00:00","sec_items":["1.01","2.03","9.01"],"event_type":"debt","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Evolent Health amends credit agreement adding $250M in new debt facilities","bullets":["Increased existing ABL revolver by $50M (with $25M funded); new delayed draw term loans of $125M and $75M.","Interest rates: ABL at SOFR + 4.00% or base + 3.00%; term loans at SOFR + 5.50% or base + 4.50%.","Maturity is earliest of 5 years from Dec 6, 2024, or 180 days before 2029 convertible notes maturity.","Borrowing under term loans requires total secured leverage ratio ≤ 2.00:1.00.","Upfront fees: 1% on ABL commitment; 2% (reducible to 1%) on term loan amounts funded."],"urls":{"canonical":"https://secwatch.observer/filing/0001628908-24-000117","json":"https://secwatch.observer/filing/0001628908-24-000117.json","markdown":"https://secwatch.observer/filing/0001628908-24-000117.md","text":"https://secwatch.observer/filing/0001628908-24-000117.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1628908/000162890824000117/0001628908-24-000117-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1628908/000162890824000117/evh-20241206.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-29T04:43:43.026826+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}